GLP-1 medicines and knee arthritis risk
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study looks at whether a type of diabetes medicine called GLP-1 analogues (like Ozempic) might affect the risk of developing osteoarthritis (a common type of arthritis that wears down joints). If you have type 2 diabetes and have been taking either a GLP-1 medicine or another type called SGLT2 inhibitors for at least a year, this trial may help you understand your joint health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 50 years
- You have type 2 diabetes (diagnosed by a doctor)
- You have been taking either a GLP-1 medicine (like Ozempic, Trulicity) or an SGLT2 inhibitor (like Jardiance, Farxiga) for at least one year
- You do not have type 1 diabetes
- You are not pregnant or breastfeeding
- You do not have autoimmune diseases, are not on corticosteroids, immunotherapies, or certain arthritis medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a type 2 diabetes medication called a GLP-1 receptor agonist (like Ozempic) is safe and effective for people on dialysis. It may help manage blood sugar and improve health outcomes for those with kidney failure.
This study tests if adding a GLP-1 medication (a type of drug that helps with weight and blood sugar) to your usual psoriatic arthritis treatment can improve your joint and skin symptoms. It is for people with psoriatic arthritis who have not yet achieved good control of their disease and have a higher body weight.
This study looks at whether taking a GLP-1 medication (a type of medicine that helps with weight and blood sugar) before hip or knee replacement surgery can improve recovery. It may help reduce complications and improve outcomes for people who are overweight or have obesity-related health conditions.
This study compares two different steroid knee injections—Zilretta and Kenalog—to see which works better for people with both knee osteoarthritis and type 2 diabetes. It uses a continuous glucose monitor to track blood sugar changes.
This trial tests whether metformin, a common diabetes medicine, can prevent arthritis after an ACL injury. If you are planning to have ACL surgery soon, you may be able to join.
This study tests if a type 2 diabetes medication (SGLT2 inhibitor) can help people with frequent gout flares. It aims to lower uric acid levels and reduce flare-ups.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.